NVO
NVO
US6701002056
Novo Nordisk A/S
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 309.064.000.000 290.403.000.000
6.4%
Cost of Revenue 58.788.000.000 44.522.000.000
32.0%
Gross Profit 250.276.000.000 245.881.000.000
1.8%
122.618.000.000 117.542.000.000
4.3%
Operating Income 127.658.000.000 128.339.000.000
0.5%
Pretax Income 130.540.000.000 127.191.000.000
2.6%
Net Income Common Stockholders 102.434.000.000 100.988.000.000
1.4%
-- --
--
-- --
--
ende